基于LI-RADS的MR特征识别肝细胞癌的细胞角蛋白19表达状态
该回顾性研究纳入201例患者共207个肝细胞癌病灶,评估基于LI-RADS v2017的MR特征识别CK19表达状态的价值。CK19阳性组较阴性组更常见靶样外观,非周边「廓清」和非环状动脉期高强化更少见。多因素分析显示AFP>20 ng/ml、靶样外观和非周边「廓清」为CK19阳性的独立预测因子。
要点
- 靶样外观在CK19阳性肝细胞癌中更常见(p=0.001)。
- 非周边「廓清」和非环状动脉期高强化在CK19阳性肝细胞癌中更少见(p<0.0001)。
- AFP>20 ng/ml(OR=5.9)、靶样外观(OR=4.2)和非周边「廓清」(OR=0.2)为CK19阳性独立预测因子。
核心结论
- 靶样外观和非周边「廓清」缺失联合AFP升高有助于区分CK19阳性与阴性肝细胞癌。
研究设计与样本
- 回顾性研究,纳入201例患者共207个肝细胞癌病灶,均行MR检查,以LI-RADS v2017特征及临床数据比较CK19阳性组(n=51)与CK19阴性组(n=156)。
关键影像表现/征象
- 靶样外观在CK19阳性组较CK19阴性组更常见(p=0.001)。
- 非周边「廓清」在CK19阳性组较CK19阴性组更少见(p<0.0001)。
- 非环状动脉期高强化在CK19阳性组较CK19阴性组更少见(p<0.0001)。
诊断标准与关键数值
- 多因素分析中,血清甲胎蛋白>20 ng/ml预测CK19阳性肝细胞癌的OR=5.9。
- 多因素分析中,靶样外观预测CK19阳性肝细胞癌的OR=4.2。
- 多因素分析中,非周边「廓清」预测CK19阳性肝细胞癌的OR=0.2。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To retrospectively evaluate the value of MR features based on Liver Imaging Reporting and Data System (LI-RADS ver.2017) for identifying the status of cytokeratin (CK) 19 expression of HCC before surgery.
METHODS: A total of 201 patients with 207 HCCs who underwent MR imaging were reviewed retrospectively. MR features based on LI-RADS ver.2017 as well as clinical data were compared between CK19-positive (n = 51) and CK19-negative (n = 156) HCCs groups. Potential predictive parameters were identified by univariate and multivariate logistic regression analysis and diagnostic odds ratios (ORs) were recorded.
RESULTS: MR features including targetoid appearance (p = 0.001) was more frequently observed while non-peripheral "washout" (p < 0.0001) and non-rim arterial phase hyper-enhancement (p < 0.0001) were found less frequently in CK19-positive HCCs compared to CK19-negative HCCs. At multivariate analysis, serum alphafetoprotein (AFP)>20 ng/ml (OR = 5.9) and targetoid appearance (OR = 4.2) and non-peripheral "washout" (OR = 0.2) were significant independent predictors of CK19-positive HCCs.
CONCLUSION: Targetoid appearance and absence non-peripheral "washout" combined with elevated AFP were useful for differentiating CK19-positive HCCs from CK19-negative HCC.
引用
- Hu XX, Wang WT, Yang L, et al. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas. Eur J Radiol. 2019. PMID: 30927962. doi:10.1016/j.ejrad.2019.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。